Variant report
Variant | nsv965129 |
---|---|
Chromosome Location | chr3:162769084-162776730 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200504044 | chr3:162769084-162769085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146295624 | chr3:162769107-162769108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150949082 | chr3:162769138-162769139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9823925 | chr3:162769145-162769146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs188783500 | chr3:162769184-162769185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533124260 | chr3:162769203-162769204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9824108 | chr3:162769266-162769267 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs530005630 | chr3:162769274-162769275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543916847 | chr3:162769287-162769288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200907721 | chr3:162769303-162769304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9841791 | chr3:162769378-162769379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs531570458 | chr3:162769403-162769404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140782821 | chr3:162769404-162769405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375268784 | chr3:162769419-162769420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150128561 | chr3:162769423-162769424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35895206 | chr3:162769431-162769432 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs9841958 | chr3:162769497-162769498 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541973345 | chr3:162769508-162769509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74637674 | chr3:162769594-162769595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114399312 | chr3:162769600-162769601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546933952 | chr3:162769613-162769614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78129353 | chr3:162769625-162769626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs77130212 | chr3:162769630-162769631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34942202 | chr3:162769678-162769679 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs73016993 | chr3:162769742-162769743 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs541759860 | chr3:162769821-162769822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540459733 | chr3:162769882-162769883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191678787 | chr3:162769901-162769902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543439646 | chr3:162769914-162769915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34872399 | chr3:162769937-162769938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs577266117 | chr3:162769944-162769945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141430032 | chr3:162769947-162769948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564747592 | chr3:162769970-162769971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147019191 | chr3:162769980-162769981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139012734 | chr3:162769989-162769990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185341169 | chr3:162769997-162769998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6548368 | chr3:162770007-162770008 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs564259734 | chr3:162770029-162770030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs11705866 | chr3:162770197-162770198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555800311 | chr3:162771608-162771609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182396701 | chr3:162771609-162771610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574571898 | chr3:162771610-162771611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4858904 | chr3:162771611-162771612 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs35691841 | chr3:162771623-162771624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530260220 | chr3:162771624-162771625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78443389 | chr3:162771641-162771642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542160155 | chr3:162771651-162771652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560462195 | chr3:162771652-162771653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4858905 | chr3:162771666-162771667 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs4858906 | chr3:162771685-162771686 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162769000-162770200 | Enhancers | Dnd41 | blood |
2 | chr3:162771600-162772000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:162775000-162776400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr3:162775400-162775800 | Enhancers | Colon Smooth Muscle | Colon |
5 | chr3:162775400-162776000 | Enhancers | Stomach Smooth Muscle | stomach |
6 | chr3:162775600-162776200 | Enhancers | Adipose Nuclei | Adipose |
7 | chr3:162775600-162776400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr3:162775600-162776600 | Enhancers | Fetal Stomach | stomach |
9 | chr3:162775600-162776600 | Enhancers | Rectal Smooth Muscle | rectum |
10 | chr3:162775800-162776200 | Flanking Active TSS | Colon Smooth Muscle | Colon |
11 | chr3:162776000-162776200 | Flanking Active TSS | Stomach Smooth Muscle | stomach |
12 | chr3:162776000-162776400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr3:162776000-162776600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr3:162776000-162776600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr3:162776200-162776600 | Enhancers | Fetal Lung | lung |
16 | chr3:162776200-162776600 | Enhancers | Fetal Muscle Leg | muscle |
17 | chr3:162776200-162776600 | Active TSS | Stomach Smooth Muscle | stomach |
18 | chr3:162776200-162776800 | Enhancers | Colon Smooth Muscle | Colon |
19 | chr3:162776600-162777600 | Weak transcription | Fetal Stomach | stomach |